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Purpose: To assess the appropriateness and compliance of antibiotic prophylaxis practices in cardiac 
surgery in a tertiary hospital in United Arab Emirates (UAE) using three international guidelines. 
Methods: A retrospective study was performed by reviewing patients’ files admitted for cardiac surgery 
between January 2008 and February 2010. The study evaluated the adherence of health care 
professionals to three international guidelines with regard to antibiotic prophylaxis. The guidelines were 
National Surgical Infection Prevention Project (NSIPP), Society of Thoracic Surgeons (STS) and 
American College of Cardiology/American Heart Association (ACC/AHA).  Patients’ records were 
reviewed for antibiotics used for prophylaxis, frequency of administration, timing and number of doses.  
Results: A total of 92 patients were included in the study. Based on the international guidelines, only 
89.1 and 79.3% of the patients received the recommended pre- and post-operative antibiotics, 
respectively. On the other hand, 93.5% of the patients received the right antibiotic dose while the total 
duration of all antimicrobial agents used for prophylaxis was concordant with the guidelines (48 h) in 
only 67.4% of the patients.  
Conclusion: Adherence to international antimicrobial prophylaxis guidelines for cardiac surgery was 
found to be suboptimal in the study hospital in Dubai. Various interventions are needed via developing 
local evidence-based protocols in collaboration with surgeons, and also to strengthen regulations for 
ensuring adherence to these guidelines. 
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INTRODUCTION 
 
Surgical site infection (SSI) represents one of 
the most common nosocomial infections; its 
incidence rate is estimated to be in the range 
of 2 – 5% in patients undergoing clean extra-
abdominal operations and up to 20% in 
patients undergoing intra-abdominal 
operations [1]. Although cardiac surgery is 
generally considered a clean procedure, 
several studies have shown that significant 
morbidity and mortality are associated with 
major cardiovascular surgery [2]. Antibiotic 
prophylaxis has been demonstrated to lower 
the incidence of SSI [3]. 
 
The vast body of literature addressing the 
prevention of the incidence of SSIs have 
been summarized and published in several 
international guidelines to properly direct 
physicians and other health care providers in 
their clinical decision making  by describing 
the  generally accepted approaches for the 
diagnosis, management or prevention of 
certain disease conditions [4]. Among these 
are the American College of 
Cardiology/American Heart Association 
(ACC/AHA) [5], the National Surgical 
Infection Prevention Project (NSIPP) [6] and 
the Society of Thoracic Surgeons (STS) [3,4]. 
The three international guidelines are well 
accepted standards published and can easily 
be accessed for guidance in antimicrobial 
prophylaxis in cardiac surgery. There are no 
major differences between the selected 
international guidelines.    
 
The recommendations made by these 
guidelines can be summarized as follows: a) 
antimicrobial prophylaxis should be given to 
all patient undergoing cardiac surgeries, b) 
the antibiotics of choice are first or second 
generation cephalosporin (cefazolin or 
cefuroxime), c) vancomycin should be 
reserved for patients with known cases of 
methicillin-resistant Staphylococcus aureus 
(MRSA) or for patients with allergy to beta-
lactams, d) the duration of antimicrobial 
prophylaxis should be no longer than 48 h 
with the first dose given to the patient within 
60 min prior to skin incision. Therefore, the 
timing for antimicrobial prophylaxis is 
considered optimal if administered within 30 
to 60 minutes before incision.  
 
In the United Arab Emirates (UAE), there is 
no national drug policy in place and 
antimicrobial prophylaxis in cardiac surgery 
and hence there is no standard protocol that 
cuts across all health facilities in UAE. 
Several non-unified local protocols exist in 
different health care facilities regarding 
antimicrobial prophylaxis in cardiac surgery. 
Studies on current practice of antimicrobial 
prophylaxis in cardiac surgery appear to be 
lacking in UAE and there is a need to 
generate baseline data on the pattern of 
prophylactic antibiotic use in cardiac surgery.  
The purpose of this study was to assess the 
appropriateness and compliance of antibiotic 
prophylaxis practices in cardiac surgery to 
three international guidelines (NSIPP, STS 




Setting and study design 
 
This study was conducted in a tertiary 600-
bed hospital providing general medical and 
surgical services. The hospital is located in 
Dubai which is one of the largest cities (by 
area and population) in the United Arab 
Emirates (UAE).  
 
Following approval by the Research 
Committee in Dubai Pharmacy College, the 
case files of patients admitted for cardiac 
surgery during the period of January 2008 
and February 2010 were reviewed 
retrospectively. The files included in the study 
were those of patients who had cardiac 
surgery. Patients who were diagnosed with 
human immunodeficiency virus (HIV) 
infection, tuberculosis, or cystic fibrosis were 
excluded. Patient records documenting 
suspected infections other than SSI which 
required antibiotic administration were also 
excluded from the study.  
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Data collection 
 
Data were collected from patients’ records, 
medication sheets, and prescriptions using a 
clinical data collection form. The developed 
form was tested prior to the study on a small 
pilot sample (n = 8) and subsequently 
modified to ensure that the data are valid. 
The data collection form had two sections. 
Section I included 1) Patient demographic 
information, i.e., patient’s file number, 
gender, age, weight, date of admission and 
date of discharge; and 2) Medical 
information, i.e., diagnosis, type of surgery, 
past medical history, drug history, drug 
allergy, antibiotic use in the last 2 weeks and 
previous hospitalization in the last 2 years. 
Section II included 1) antibiotic use or non-
use and type of prophylactic antibiotic(s) 
used during surgery incorporating scientific 
name, dose, frequency, timing of doses, 
route of administration, duration of use, and 
number of doses of all antibiotics used (pre-, 
intra-, and post-operatively) as surgical 
prophylactic antibiotics; and 2) duration of 
surgery in minutes. 
 
A total of 108 patient records of those who 
had cardiac surgery were identified during the 
study period. Five records were excluded 
from the study; three of these records were 
for patients with tuberculosis, one with 
pneumonia and one with suspected infection 
that required antibiotic therapy. Additional 11 
patient records could not be evaluated due to 
incomplete or missing information. In all, 92 
patient records were thus eligible for the 




Data were coded, entered into a spreadsheet 
and analyzed using SPSS® version 16 (SPSS 
Inc., Chicago, IL). Descriptive statistics were 
carried out for all assessed parameters and, 
where appropriate, the results were 






Of the 92 patients included in the study, 73 
were males while 19 were females. The 
average age of the patients was 48.7 ± 19.3 
years (median = 51 years) and the mean 
weight was 15.9 ± 22.2 kg. About 40% of the 
patients had normal body weight (BMI, 18.5 - 
24.9 kg/m2), 33.7% were overweight, 16.3% 
obese and 9.8% underweight.  About 32.0% 
of the patients were smokers and 5.4% quit 
smoking a year earlier. A majority of the 
patients (84.8%) currently drink coffee while 
9.8% take alcoholic beverages. About half 
(53.3%) of the patients were diagnosed with 
three or more medical conditions. The 
majority of patients (78.3%) were admitted for 
coronary artery bypass with a mean surgery 





Antibiotic prophylaxis was received by 90 
patients (97.8%) while post-operative doses 







Antibiotic choice pre-operation was in 
accordance to guidelines  in 89.1% of 
patients who received cefuroxime  while the 
antibiotic choice in 10 patients (10.9%) did   
not adhere to guidelines due to (a) three 
patients were given cefuroxime even when 
they had documented beta-lactam allergy, (b) 
unexplained administration of cefuroxime and 
metronidazole combination in one patient, (c) 
unexplained use of piperacillin sodium and 
tazobactam odium as pre-operative 
prophylactic antimicrobial agent in four 
patients, and (d) no administration of 
antimicrobial prophylactic dose in two 
patients due to urgency of the cardiac 
surgery The data obtained are presented in 
Table 2. 
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Table 1: Characteristics and types of cardiac surgeries for enrolled patients 
 
Characteristic N (%) 







Patient Average weight (kg) 66.0±22.0 
Underweight (BMI = 18.5kg/m2)  9 (9.8) 
Normal weight (BMI = 18.5-24.9kg/m2)   37 (40.2) 
Overweight (BMI = 25-29.9kg/m2)  31 (33.7) 
Obese (BMI=. 30kg/m2)  15 (16.3) 
Mean length of hospital stay before surgery (days)   5.5 ± 3.3 
Mean total length of hospital stay (days)   18.2± 10.6 
Hospitalization in the past 2 years  46 (50) 
Diabetes mellitus  46 (50) 
Current smoker  





Three medical diagnoses or more  49 (53.3) 
Type of cardiac surgery   
Congenital heart surgery  12 (13) 
Valve replacement surgery  6 ( 6.5) 
Coronary artery bypass surgery  72  (78.3) 
Other surgeries  2 (2.2) 
Mean duration of surgery (hours)  4.6 ± 1.58 
 
Table 2: Antimicrobials utilized pre- and post-surgical operations. 
Treatment N (%) 
Pre-operative  
Cefuroxime 82 (89.1) 
Cefuroxime although documented B-lactam allergy is present 3 (3.3) 
Cefuroxime and metronidazole combination 1 (1.09) 
Other therapeutic category (Piperacillin sodium and tazobactam sodium combination) 4 (4.35 ) 
No treatment due to urgency 2 (2.17) 
Subtotal 92 (100) 
Post-operative   
Cefuroxime 73(79.3) 
Levofloxacin+ flucloxacillin 1 (1.1) 
Cefuroxime + Levofloxacin 1 (1.1) 
Cefuroxime + Ciprofloxacin 1 (1.1) 
Cefuroxime + Doxycycline 1(1.1) 
Cefuroxime + (Piperacillin sodium and tazobactam Sodium combination) 3 (3.26) 
(Piperacillin sodium and tazobactam sodium combination) 2 (2.17) 
(Piperacillin sodium and tazobactam sodium combination)+Levofloxacin 1 (1.10) 
(Piperacillin sodium and tazobactam sodium combination)+Levofloxacin+ Cefuroxime 4 (4.35) 
None 5 (5.43) 
Subtotal 92 (100) 
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Post-operative therapy 
 
After surgery, almost 79.3% of the patients 
were given the correct antibiotic treatment 
(cefuroxime) with only 15.2% of patients 
switched from appropriate antibiotic to an 




The dose given was in accordance with 
guidelines in 86 patients (93.5%), as shown 
in Table 3. In the remaining six patients 
(6.5%), the dose was not in agreement with 
the guidelines’ recommendations on the 
calculated dose per body weight for four 
patients. Two patients did not take any 
antibiotic due to urgency in performing the 
operations. 
 
Total duration of antimicrobial 
prophylaxis  
 
In 62 out of 92 patients (67.4%), the total 
duration of use of all antimicrobial agents for 
prophylaxis was concordant with the 
guidelines (48 h) while in 30 patients (32.6%) 





Intra-operative dose was given to 17 patients 
out of the 92 patients (18.5%). The duration 
of surgical procedure was equal ≤ 3 h in 12 
patients out of the 17 patients; no additional 
dose of the prophylactic agent was required 
intra-operatively as per the guidelines. On the 
other hand, no intra-operative dose was 
administered to 75 patients (81.5%); 74 
patients were subjected to surgical procedure 
longer than 3 h (average duration = 7 h). The 
data are presented in Table 3.  
 
Timing of doses given pre-operatively 
 
For doses given pre-operatively (Table 3), 
timing was in accordance to the guidelines 
(60 min before incision) in only 30.4% (n = 
28) of the patients while it was given < 60 min 
in 58.7% (n = 54) and > 60 min in 8.7% (n = 
8). The remaining two patients (2.2%) did not 
 
Table 3: Adherence to the guidelines on dose, duration of antimicrobial use, dosing interval and 
dosing time 
 
Parameter N (%) 
Dose  
In accordance with guidelines 86 (93.5) 
Dose n Not in accordance with guidelines 6 (6.5) 
Duration of antimicrobials use   
In accordance with guidelines 62 (67.4) 
Not in accordance with guidelines 30 (32.6) 
  











In accordance with guidelines 
Not in accordance with guidelines 
Not intra-operative dose 
In accordance with guidelines 
Not in accordance with guidelines 
Time of dosing 
In accordance to guidelines (30-60 min) 
Not in accordance with guidelines (< 30 min) 
Not in accordance with guidelines (> 60 min) 
No antibacterial prophylaxis  2 (2.2) 
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take any prophylactic dose due to the 





The principal finding of our study was that 
adherence to guidelines for antibiotic 
prophylaxis in cardiac surgery was not 
achieved 100% for all parameters in any of 
the 92 cardiac surgeries assessed in the 
study. However, these results are not 
surprising and are consistent with similar 
results obtained from studies done in some 
Middle East countries where rates of 
complete adherence to practice guidelines 
were 0 [7], and 0.3% [8] in Jordan and Iran, 
respectively. In addition, other studies carried 
out in Western countries reported that 
adherence to antimicrobial prophylaxis 
guidelines were relatively higher than those 
found for Middle Eastern countries [9,10]. 
 
Of all the patient files reviewed, 97.8% 
received antibiotic prophylaxis before 
operations. Similar studies in Belgium and 
Greece reported reported 71 and 70%, 
respectively[11,12]. In this study only 30.4% 
of patients were given prophylactic dose on 
time as stipulated in the guidelines. This 
represent a very low percentage compared to 
other studies which reported 100% of 
patients as having received the dose on time 
[12]. This should attract attention of who 
should be designated to enforce the routine 
of initiation of prophylaxis at the time of 
induction of anesthesia by the 
anesthesiologist. 
 
Post-operation prophylactic dose was 
appropriately given to 79.3% of patients with 
15.2% of the patients switched from 
appropriate antibiotic to an inappropriate 
agent. Switches were made from a second 
generation cephalosporin (cefuroxime) to 
different combinations This unexplained 
switch to third-generation cephalosporin or 
broad spectrum combinations is not 
recommended for SSI prophylaxis since they 
have less activity against Staphylococci and 
may induce the emergence of resistant 
organisms as well as increase the cost 
burden [13]. 
 
Total duration of antimicrobial prophylaxis 
was in accordance with guidelines in 67.4% 
of patients and but longer in 32.6% of the. 
Nonetheless, one or two doses are often 
enough to achieve antimicrobial prophylaxis 
over a 48-h period [14]. Most surgeons 
perceive that there is a need for prolonged 
administration of antimicrobial prophylaxis 
[15] and therefore, often use their own 
judgment. It appears that they have  difficulty 
in accepting the new evidence about 
antibiotic prophylaxis [16].   
  
In this study, adherence to all the guidelines’ 
recommendations was not completely 
achieved in any patient enrolled in the study. 
However, there appears to be better 
adherence in the dosing of prophylactic 
agents used and duration of antibiotic use, 
but lower than figures from other studies that 
reported 100.0 and 99.1%, respectively) [7]. 
 
This seems to indicate minimal awareness on 
the part of surgeons regarding the 
importance of giving antimicrobial prophylaxis 
to prevent SSI in cardiac surgeries compared 
to other countries. 
 
Assessing the feasibility, appropriateness 
and acceptance of clinical guidelines among 
surgeons is very important to ensure effective 
implementation [17]. We can conclude that if 
adherence to such guidelines is not 
improved, the incidence of surgical-site 
infections may increase and lead probably to 
increase in antimicrobial resistance [18]. 
 
Development and implementation of standard 
treatment protocols are the best approach to 
improving surgeons’ adherence to guidelines, 
either by adopting international guidelines or 
by developing a suitable local one. This 
should be done with the contribution of 
surgeons as well as anesthesiologists, 
microbiologists, pharmacists and infection 
control departments. These guidelines should 
take into consideration hospital-specific 
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bacterial epidemiological patterns and secure 
the consensus of all surgeons working in the 
hospital before its implementation [7]. 
 
Clinical pharmacists also need to play an 
important role in the implementation of such 
guidelines as they should be charged with the 
responsibility of ensuring administration of 
prophylactic dose to patients’ prior to and 
after surgery. As demonstrated by Prado et al 
in his study which showed that pharmacists 
made a big improvement when they took 
charge of the administration of antimicrobial 
prophylaxis and assessing the 
appropriateness of the indications; adherence 
increased from 56 to 100% while the costs 
was decreased by 40% [19]. 
 
Although the cost analysis for developing SSI 
was not addressed in our study, SSI is a cost 
burden on the healthcare system. It has been 
reported that surgical-site infections could be 
costing European healthcare systems 
between 1.47 and 19.1 billion euros each 
year [20]. 
 
Limitations of the study 
 
The small number of patients involved in the 
study does not permit drawing inferences that 
applies to the entire population. A larger 
study is needed to assess antimicrobial 
prophylaxis practice in several hospitals and 
to be able to generalize our findings to the 
whole country. As this study is a retrospective 
study, we assume that our data is accurate, 
as recorded by anesthesiologists and 




Adherence to the international antimicrobial 
prophylaxis guidelines for cardiac surgery 
was found to be suboptimal in the 
investigated hospital in Dubai. The results 
highlight the challenges faced in transferring 
evidence-based protocol to clinical practice. 
Various interventions are needed to 
overcome this problem. Developing local 
evidence-based protocols in collaboration 
with surgeons, and strengthening regulations 
would be important in ensuring adherence to 
these guidelines. Conducting several 
seminars to discuss and analyze antibiotic 
prescribing patterns and increase outcome-
based research, as well as documenting 
benefits and cost effectiveness of appropriate 
antibiotic use are also important in improving 
antibiotic prescribing in hospital settings. In 
addition, the level of adherence to antibiotic 
use in cardiac surgery guidelines could be 
optimized by integrating clinical pharmacists 
into the practice by playing a role in the 
administration, monitoring, and intervention of 
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